In this way, TIGIT can indirectly inhibit the priming of tumor-reactive T cells but TIGIT engagement can also directly induce T cell inhibition by blocking T cell activation, proliferation, and acquisition of effector functions (34). The gene discussed is TIGIT; the disease is neoplasm.